{"text": "gild alxo gilead misses first interim for magrolimab phase 3 now saying they need to show os benefit this mechanism continues to underwhelm ftsv another fantastic acquisition"}
{"text": "5 fda decisions to watch in the first quarter lly gild bmrn acad"}
{"text": "good morning our jpm23 coverage starts in minutes on first up gild ceo dan o day then in the 8amet 5ampt hour new biib ceo chris viehbacher what do you want to know"}
{"text": "gild says it repurchased 1 4b in shares in 2022"}
{"text": "mrk gild a pullback to their moving averages today"}
{"text": "gild bd on 2023 to look like 2022"}
